ClinicalTrials.govpublic full text
HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC
hepatocellular carcinoma, lenvatinib, pd-1 antibody, oxaliplatin, 5-fluorouracil and leucovorin, hepatic arterial infusion chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992472
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.